Lena Hagman

Insider profile

Performance

Overall performance
1.9
Performance over holding periods
1.9
30 days 90 days 120 days
Average return 5% 8.2% 15.1%
Success rate 35% 68% 82%
Transactions
2 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Lena Hagman's trades of Xvivo Perfusion AB's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
245.10
Quantity 78,751
Value SEK3,903,309
Transaction date
Purchase
Price
315.15
Quantity 30,734
Value SEK2,073,237
SE Getinge AB (GETI-B)
Transaction date
Purchase
Price
214.33
Quantity 6,478
Value SEK4,365,288
SE Getinge AB (GETI-B)
Transaction date
Purchase
Price
127.00
Quantity 28
Value SEK3,556
SE Getinge AB (GETI-B)
Transaction date
Purchase
Price
143.73
Quantity 3,000
Value SEK431,190
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-11-18 2025-11-18
B Purchase
78,751
245.10
SEK3,903,309 		78,751 245.10 SEK3,903,309
2025-04-28 2025-04-28
B Purchase
30,734
315.15
SEK2,073,237 		30,734 315.15 SEK2,073,237
2017-09-10 2017-09-05
SE Getinge AB (GETI-B)
B Purchase
6,478
214.33
SEK4,365,288 		6,478 214.33 SEK4,365,288
2017-09-10 2017-09-05
SE Getinge AB (GETI-B)
B Purchase
28
127.00
SEK3,556 		28 127.00 SEK3,556
2017-08-17 2017-08-16
SE Getinge AB (GETI-B)
B Purchase
3,000
143.73
SEK431,190 		3,000 143.73 SEK431,190